Clinical trial
Sulindac and Plant Compounds in Preventing Colon Cancer
NCT00003365 · University of Medicine and Dentistry of New Jersey, Other · Terminated
Key facts
| NCT number | NCT00003365 |
|---|---|
| Title | Sulindac and Plant Compounds in Preventing Colon Cancer |
| Official title | The Effect of Plant Phenolic Compounds on Human Colon Epithelial Cells |
| Lead sponsor | University of Medicine and Dentistry of New Jersey, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Terminated |
| Study type | Interventional |
| Conditions | Colorectal Cancer |
| Intervention type | Dietary Supplement, Drug |
| Interventions | curcumin, rutin, quercetin, sulindac |
| Start date | Aug 1, 1996 |
| Primary completion | Jul 1, 2006 |
| Completion | Jul 1, 2006 |
| First posted | May 21, 2004 |
| Last update posted | Jan 27, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: